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INTRODUCTION
The diagnosis and treatment of childhood cancer is a dramatic
event that affects the daily life and emotional well-being of all
family members [1–3]. The enormous increase in survival [4–8]
has heightened the need to investigate the consequences of
childhood cancer. An increasing number of studies have been
directed at assessing Health Related Quality of Life (HRQoL) in
long-term survivors, and considerable literature has been devoted to
the pediatric patients and their parents during cancer treatment
[1,9,10]. Less is known about what happens in the first few years
after treatment in the run-up to long-term survivorship. Longitudinal
studies are sparse, especially among preschool patients, whereas the
number of children with cancer in this age group is relatively high.
The first few years following the end of successful treatment are
considered as an important phase in the adjustment to the cancer
experience. Coming off therapy is one of the major transitions in
care in the practice of pediatric oncology [11]. A longitudinal study
was focused on answering the following questions: [1] how is the
course of HRQoL of preschool survivors during the first 3 years of
continuous remission following the completion of treatment for
cancer? [2] To what extent are demographic and medical variables
and parental psychological distress associated with HRQoL of
preschool survivors during the first 3 years of continuous remission
following the completion of treatment for cancer? Although a 5-year
period without treatment is commonly considered a criterion of
survival, the patients in our study were called survivors because they
were in continuous remission in the period approaching long-term
survivorship.
METHODS
Procedure
The results presented here are taken from the VOLG-study, a
Dutch study on the psychosocial consequences of cancer in
childhood, which started in the year 2000 and ended in 2006. From
2000 to 2002, survivors and their parents were recruited from the
Emma Children’s Hospital at the Academic Medical Center in
Amsterdam and the Radboud University Nijmegen Medical Center.
The Medical Ethics Committee of the two Dutch hospitals has
approved the study protocol.
The inclusion criteria were: [1] age of the survivors 1–18 years,
[2] complete remission, [3] end of successful treatment at most
2 months before, and [4] ability to complete Dutch questionnaires.
The data of survivors aged 1–5 years (‘‘preschool survivors’’) with
leukemia, lymphoma or solid tumors were used in this article.
Once informed consent had been obtained, the researcher
assigned the questionnaire about HRQoL of preschool survivors at
random to the father or the mother. The assigned parents complet-
ed the questionnaires four to six times depending on the year
of inclusion. The first four assessments were used for analyses;
approximately 2 months (M1), 1 year (M2), 2 years (M3), and 3 years
(M4) after the end of treatment. The data for survivors who relapsed
were excluded from analysis from the moment of the relapse.
Background. The aim of the study was to access Health Related
Quality of Life (HRQoL) in preschool cancer survivors during the first
3 years of continuous remission after the end of successful treatment,
and to identify predictors of HRQoL. Procedure. Parent-reported
HRQoL was assessed in 53 preschool children treated successfully
for cancer, using the TAPQOL and compared with norm data.
Longitudinal mixed models analyses were performed to investigate
to what extent demographic and medical variables and parental
psychological distress were predictive of HRQoL over time.
Results. Two months after the end of successful cancer treatment,
survivors showed significantly (P<0.01) more problem behavior and
anxiety, and scored significantly worse (P<0.01) on sleeping, motor
functioning, positive mood and liveliness than the norm. One year
after the end of treatment survivors still showed significantly
(P<0.01) more anxiety and worse motor functioning. The level of
HRQoL in survivors had normalized 2 and 3 years after the end of
treatment. Longer duration of treatment, bad prognosis and greater
parental psychological distress were associated with worse scores on
the Physical Component Score of the TAPQOL. Medical variables
and parental psychological distress were not associated with the
Mental Component Score. Conclusions. Survivors adjusted well to
the cancer experience and HRQoL improved with time. Despite
overall resilience in survivors over time, physical as well as
psychosocial monitoring in follow-up is recommended. Standard
aftercare should preferably include psychosocial screening, educa-
tion, and counseling directed at both survivors and parents. Pediatr
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Measures
HRQoL was assessed with the TNO-AZL Preschool Quality of
Life questionnaire for children aged 1–5 years (TAPQOL), which
assesses the child’s functioning on 12 domains: sleeping, appetite,
lungs, stomach, skin, motor functioning, social functioning,
problem behavior, communication, anxiety, positive mood, and
liveliness. Higher scores indicate better HRQoL [12,13]. Following
the method of Ware et al. [14], we used Principal Components
Analysis (oblique rotation) at M1 to aggregate all TAPQOL scale
scores into two summary scales: Mental Component Scale (MCS)
and Physical Component Scale (PCS).
Parental psychological distress was measured using the General
Health Questionnaire-30 (GHQ-30). The raw total scale score can
be used as an overall index of psychological distress, where higher
scores indicate greater distress [15,16].
Medical data were obtained from the survivor’s medical record.
The prognosis was based on the survival chances at diagnosis as
rated by each survivor’s oncologist, viz.<25%, 25–75%, or>75%.
After the end of treatment (M1), the parents rated their perception of
the intensiveness of their child’s treatment on a Visual Analogue
Scale, from ‘‘totally non-intensive’’ (0, left end of line) to ‘‘very
intensive’’ (10, right end of line). They were also asked to assess the
visible consequences of the disease. Their answers were dichotom-
ized to ‘‘presence’’ or ‘‘absence’’ of visible consequences.
Important family events (other than the cancer of the child)
during the past year were scored by the parents on a list of 19 such
events, including the birth of a child, parental divorce, moving,
death of a family member or friend, and decline in financial means.
The total score of important family events was dichotomized to
‘‘less than two’’ and ‘‘two or more.’’
Statistical Analyses
SPSS version 12.0 was used for all analyses. One sample t-tests
or non-parametric equivalents were performed to test whether the
TAPQOL scores of the preschool survivors differed from those in
the norm population, at a significance level of 0.01. The seven
TAPQOL scales with sufficient internal consistency at every
measurement occasion were used for these analyses: problem
behavior, anxiety, positive mood, communication, liveliness,
sleeping, and motor functioning.
Linear mixed model analysis [17] was performed to examine the
course of HRQoL and to what extent demographics, medical
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TABLE I. Characteristics of the Survivors
N
M1 2 months M2 1 year M3 2 years M4 3 years
53 38 23 17
Gender, N (%)
Girls 27 (50.9) 19 (50.0) 13 (56.5) 10 (58.8)
Boys 26 (49.1) 19 (50.0) 10 (43.5) 7 (41.2)
Age*
M (SD) 3.9 (1.4) 4.1 (1.3) 4.3 (0.8) 4.8 (0.7)
Range 1.1–5.9 2.0–5.9 2.9–5.6 3.5–5.8
Age at diagnosis*
M (SD) 2.6 (1.4) 2.1 (1.3) 1.4 (0.9) 1.1 (0.6)
Range at M1 0.3–5.3 0.3–4.5 0.3–3.4 0.3–2.3
Time since diagnosis (months)
M (SD) 14.7 (9.1) 25.3 (9.1) 34.8 (8.3) 46.3 (7.5)
Range 2.8–29.7 14.1–40.8 26.8–49.9 38.3–61.2
Duration of treatment (months)
M (SD) 12.6 (9.3) 12.4 (9.2) 10.6 (8.3) 10.3 (7.6)
Range 1.5–25.9 2.1–25.9 2.3–25.5 2.5–25.3
Diagnosis, N (%)*
Leukemia/lymphoma 24 (45.3) 15 (39.5) 7 (30.4) 4 (23.5)
Solid tumor 29 (54.7) 23 (60.5) 16 (69.6) 13 (76.5)
Treatment, N (%)*
Chemotherapy 51 (96.2) 36 (94.7) 21 (91.3) 15 (88.2)
Radiotherapy 11 (20.8) 8 (21.1) 6 (26.1) 6 (35.3)
Surgery 26 (49.1) 21 (55.3) 14 (60.9) 11 (64.7)
Autologous bone marrow transplantation 2 (3.8) 2 (5.3) 2 (8.7) 2 (11.8)
Other 2 (3.8) 2 (5.3) 2 (8.7) 2 (11.8)
Prognosis at diagnosis, N (%)*
<25% 4 (7.5) 4 (10.5) 4 (17.4) 4 (23.5)
25–75% 20 (37.7) 13 (34.2) 10 (43.5) 8 (47.1)
>75% 29 (54.7) 21 (55.3) 9 (39.1) 5 (29.4)
Relapse, N 0 0 0 0
Respondent, N(%)
Mother 34 (64.2) 26 (68.4) 18 (78.3) 14 (82.4)
Father 19 (35.8) 12 (31.6) 5 (21.7) 3 (17.6)
*Significant differences at <0.1 between survivors with and without TAPQOL data up to M4.
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variables and parental psychological distress were predictive
of HRQoL (PCS and MCS) over time, while controlling for
important family events. Measurement occasions were treated as
fixed because growth-curve models were not appropriate for these
data. Because of the large number of predictor variables in relation
to the sample size, preselection was necessary. The initial model
consisted of the random intercept M1 and the fixed parameters for
measurement occasions M2 to M4. Predictor variables were entered
one by one into the initial model. If significant at least at the 0.15
level, variables were selected for the final model. Compound
symmetry appeared the best longitudinal covariance structure for
PCS, where for MCS an autoregressive structure was more
appropriate. We found that it was not necessary to add any first-
order interaction effect of measurement occasion with the other
predictor variables, at Bonferroni adjusted level of significance.
To facilitate interpretation of regression coefficients, continuous
scores were transformed into standard normal scores, expressing
deviations from the mean at M1. We considered standardized
regression coefficients of 0.1 as small, 0.3 as medium and 0.5 as
large after Cohen [18]. For binary coded predictor variables,
regression coefficients of 0.2 can be considered small, 0.5 medium
and 0.8 large.
RESULTS
Participants
The parents of 66 consecutive preschool children whose cancer
treatment had successfully been ended, were invited to participate in
the VOLG-study. The response rate was 81.8% (N¼ 54); 34 mothers
and 20 fathers. The 12 survivors whose parents did not participate, did
not differ from participating survivors with respect to demographic
and medical variables (P< 0.1 in t-tests orw2-tests). One survivor was
excluded from analyses because she had a brain tumor.
TAPQOL data of 53 survivors were available at M1, 38 at M2
(71.7%), 23 at M3 (43.4), 17 (32.1%) at M4. For 36 survivors
TAPQOL data were not available up to M4 (‘‘incomplete data’’).
The main reason for incomplete data was that if a survivor reached
the age of 6 years (N¼ 26, 49.1%), the TAPQOL could not be filled
in any longer. Dropout because of non-response was 7.5% (N¼ 4).
Furthermore, if a patient suffered from a relapse, the corresponding
data from subsequent measurement occasions were excluded from
analyses (N¼ 6, 11.3%).
At M1, survivors with incomplete data did not differ (P< 0.1)
from survivors with data up to M4 (‘‘complete data’’), except on one
scale: survivors with incomplete data showed less sleeping
problems at M1 than those with complete data. As a result of the
limited age range of the TAPQOL, differences between incomplete
and complete data were found in age and age-related medical
variables (Table I).
HRQoL Over Time
Two months after treatment (M1), survivors scored significantly
(P< 0.001) worse than the norm on six out of the seven TAPQOL
scales we used in the analyses (Fig. 1). The differences were large.
Compared to the norm, survivors scored worse on problem behavior
(M¼ 56.9, d¼ 0.7), anxiety (M¼ 55.8, d¼ 1.3), motor functioning
(M¼ 82.4, d¼ 3.6), positive mood (M¼ 92.9, d¼ 0.9), liveliness
(M¼ 88.8, d¼ 1.1), and sleeping (M¼ 66.9, d¼ 0.9).
One year after treatment (M2), HRQoL scores have improved
though significant differences with the norm were still present on
anxiety (M¼ 69.7, d¼ 0.4, P< 0.01) and motor functioning
(M¼ 91.9, d¼ 2.6, P< 0.001). Survivor’s level of HRQoL was
normalized 2 and 3 years after treatment (M3 and M4). Survivors did
not differ from the norm on the Communication scale at any
measurement occasion.
Predictors of HRQoL
Parameter estimates from the longitudinal mixed models
analyses of survivor’s HRQoL are shown in Table II. Apart from
the contribution of measurement occasion, Physical HRQoL (PCS)
was explained significantly by duration of treatment, prognosis, and
parental psychological distress. Longer duration of treatment, poor
prognosis (<25%), and greater parental psychological distress were
associated with worse PCS. Apart from measurement occasion, no
other variables appeared to be associated significantly with mental
HRQoL (MCS). The effects of measurement occasion and
prognosis were medium to large, while the effects of duration of
treatment and parental psychological distress were small.
Pediatr Blood Cancer DOI 10.1002/pbc
Fig. 1. HRQoL in preschool survivors over measurements occasions:
motor functioning and problem behavior (A), positive mood and anxiety
(B), liveliness and sleeping (C). Mean TAPQOL scale scores, ranging
from 0 to 100 with higher scores representing better HRQoL, that differ
significantly from the norm in the general Dutch population of children
aged 1–5 years (13) are marked: *P< 0.01, **P< 0.001.
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DISCUSSION
Preschool survivors adjusted well to the cancer experience;
as time from end of treatment increased HRQoL improved. Longer
duration of treatment and poor prognosis seemed to affect physical
HRQoL negatively. Survivors with poor prognoses have been
treated more intensively which could result in more physical
complaints. The greater psychological distress the parents experi-
enced, the worse HRQoL they reported in their child. This finding
is in line with results from previous studies on childhood
cancer but the direction of the relationship could not be determined
[19–22]. We were not able to differentiate between the impact of
parental emotions on parental perception of their child’s HRQoL
and the impact on ‘‘real’’ survivor’s HRQoL, because the parents
evaluated the HRQoL of their children as well as their own
adjustment.
Overall, thevariables in the model explained only 26% and 16% of
the variance for physical HRQoL (PCS) and mental HRQoL (MCS),
respectively. This is not surprising, given the fact that the medical
variables were assessed rather roughly and because it was too short
after termination of treatment to find late effects of treatment. The
limited impact of medical variables on HRQoL has been found in
many studies among survivors of childhood cancer [9,10].
There would be other psychosocial factors than assessed in the
present study that affect survivors’ HRQoL, for example the
interaction between the parent and their children. If parents perceive
their children’s health as very vulnerable, this could lead to
overprotection and failing to set age-appropriate limits on the
children’s behavior, which might have adverse effects for the
children [23,24]. Further research is needed to explore these
findings, especially because parents of survivors are faced with
uncertainty about the further course of the disease, which might
influence their perceptions of their children’s vulnerability.
Limitations and Implications
The problem of small sample size is inherent to research on
children, especially when children are studied longitudinally, as
different age groups need different, age-specific questionnaires.
Low power due to small sample size could have contributed to the
fact that few variables were found to be predictive of HRQoL.
Furthermore, it was necessary to preselect variables for the final
analyses. As a result of this, several medical variables were excluded
in the final models which could have led to underestimation of the
explained variance of the models. Despite the small sample size at
the last measurement occasion, longitudinal analyses were possible
because linear mixed models analyses incorporates all available
data into analysis, including data from survivors that missed one or
more measurement occasions.
Another limitation concerns the HRQoL instruments. We used
generic HRQoL measures because we wanted to compare the
survivors with the general population. The use of cancer-specific
instruments is recommended for longitudinal assessments because
this kind of instruments is more sensitive to change. Unfortunately,
HRQoL instruments translated and validated for Dutch preschool
children are not available.
Though most survivors regained a good HRQoL 2 years after the
end of successful cancer treatment, there is no reason to lean back
because of the known late effects of many treatments [25–29].
Survivors should be followed longer to be able to assess the impact
of the late effects on the survivor’s HRQoL, physical as well as
Pediatr Blood Cancer DOI 10.1002/pbc
TABLE II. Parameter Estimates for Longitudinal Regression Models of HRQoL in Survivors Aged 1–5 Years Predicted by
Measurement Occasion, Demographic and Medical Characteristics, and Parental Psychological Distress
Fixed effects Physical component score (TAPQOL) Mental component score (TAPQOL)
Measurement (deviation from end of treatment; M1)
One year (M2) 0.41* 0.41*
Two years (M3) 0.48 0.72**
Three years (M4) 0.52 0.77*
Percentage of explained variance by fixed effects 0.09 0.11
Medical and demographic characteristics
Gender survivor — —
Age survivor 0.02 0.21
Age at diagnosis 0.04 0.09
Time since end of treatment — —
Duration of treatment 0.13* 0.02
Leukemia or lymphoma (vs. solid tumors) — —
Radio- and chemotherapy — —
Prognosis< 25% 0.53* 0.20
Perceived treatment intensity — —
Visible consequences — —
Percentage of explained variance by fixed effects 0.24 0.14
Parental data
Age — —
Gender — —
Parental psychological distress (GHQ) 0.13* 0.12
Important family events (2) — —
Percentage of explained variance by fixed effects 0.16 0.27
Total number of observations 115 115
*P< 0.05; **P< 0.01.
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psychosocial. It is satisfying that monitoring and screening
survivors have become standard aftercare in many hospitals in the
last decade. Standard aftercare should preferably include psycho-
social screening, education, and counseling directed at both
survivors and parents. Providing psychosocial information on the
effects of the disease and treatment, and assisting parents in treating
the survivors as normally as possible could prevent late psychoso-
cial problems by enhancing re-entry into normal life.
ACKNOWLEDGMENT
This study has been supported and financed by the Dutch Cancer
Society.
REFERENCES
1. Eiser C. Children with cancer. The quality of life. Mahwah. New
Jersey, Londen: Lawrence Erlbaum Associates Publishers; 2004.
2. Eiser C. Practitioner Review: Long-term consequences of child-
hood cancer. J Child Psychol Psychiatry 1998;39:621–633.
3. Stevens MCG, Mahler H, Parkes S. The health status of adult
survivors of cancer in childhood. Eur J Cancer 1998;34:694–698.
4. Novakovic BUS. Childhood cancer survival, 1973–1987. Med
Pediatr Oncol 1994;23:480–486.
5. Stiller CA, Draper GJ. The epidemiology of cancer in children. In:
Vouˆte PA, Kalifa C, Barrett A, editors. Cancer in children: Clinical
management, 4th edition edn. Oxford: Oxford University Press;
1998.
6. Stiller CA, Draper GJ. The epidemiology of cancer in children. In:
Vouˆte PA, Barret A, Stevens MCG, Caron HN, editors. Cancer in
children: Clinical management, 5th edn. Oxford: Oxford Univer-
sity Press; 2005. pp. 1–16.
7. Magnani C, Pastore G, Coebergh J, et al. Trends in survival
after childhood cancer in Europe, 1978–1997: Report from
the Automated Childhood Cancer Information system project
(AGGIS). Eur J Cancer 2006;42:1981–2005.
8. Sankila R, Martos Jime´nez MC, Miljus D, et al. Geographical
comparison of cancer survival in European children (1988–1997):
Report from the Automated Childhood Cancer Information System
project. Eur J Cancer 2006;42:1972–1980.
9. Langeveld NE, Stam H, Grootenhuis MA, et al. Quality of life in
young adult survivors of childhood cancer (review). Support Care
Cancer 2002;10:579–600.
10. Stam H, Grootenhuis MA, Last BF. Social and emotional
adjustment in young survivors of childhood cancer (review).
Support Care Cancer 2001;9:489–513.
11. Nagel K, Eves M, Waterhouse L, et al. The development of an off-
therapy needs questionnaire and protocol for surivors of childhood
cancer. J Pediatr Oncol Nurs 2002;19:229–233.
12. Fekkes M, Theunissen NCM, Brugman E, et al. Development and
psychometric evaluation of the TAPQOL: A health-related quality
of life instrument for 1–5-year-old children. Qual Life Res 2000;9:
961–972.
13. Fekkes M, Bruil J, Vogels T. TAPQOL-manual. Leiden: Leiden
Center for Child Health and Pediatrics LUMC-TNO; 2004.
14. Ware JE, Kosinski M. Interpreting SF-36 summary health
measures: A response. Qual Life Res 2001;10:405–413.
15. Goldberg DP, Williams P. A user’s guide to the General Health
Questionnaire. Windsor: NFER-Nelson; 1988.
16. Koeter MWJ, Ormel J. General health questionnaire: The Dutch
application. Amsterdam: Swets Test Services; 1991.
17. Snijders FAB, Bosker RJ. Multilevel analysis. An introduction to
basic and advanced multilevel modeling. London: SAGE Pub-
lications Ltd; 2004.
18. Cohen J. Statistical power analysis for the behavioral sciences.
New York: Academy Press; 1988.
19. Barakat LP, Kazak AE, Meadows AT, et al. Families surviving
childhood cancer: A comparison of posttraumatic stress symptoms
with families of healthy children. J Pediatr Psychol 1997;22:843–
859.
20. Kazak AE, Barakat LP. Brief report: Parenting stress and quality of
life during treatment for childhood leukemia predicts child and
parent adjustment after treatment ends. J Pediatr Psychol 1997;22:
249–758.
21. Sawyer MG, Streiner DL, Antoniou G, et al. Influence of parental
and family adjustment on the later psychological adjustment of
children treated for cancer. J Am Acad Child Adolesc Psychiatry
1998;37:815–822.
22. Sloper T, Larcombe IJ, Charlton A. Psychosocial adjustment
of five-year survivors of childhood cancer. J Cancer Educ 1994;9:
163–169.
23. Estroff DB, Yando R, Burke K, et al. Perceptions of preschoolers’
vulnerability by mothers who had delivered preterm. J Pediatr
Psychol 1994;19:709–721.
24. Stern M, Karraker K, McIntosh B, et al. Prematurity stereotyping
and mothers’ interactions with their premature and full-term infants
during the first year. J Pediatr Psychol 2006 Jul; 31:597–607.
25. Lackner H, Benesch M, Schagerl S, et al. Prospective evaluation of
late effects after childhood cancer therapy with a follow-up over
9 years. Eur J Pediatr 2000;159:750–758.
26. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Grading of late
effects in young adults survivors of childhood cancer followed in an
ambulatory adult setting. Cancer 2000;88:1687–1695.
27. Oeffinger KC, Hudson MM. Long-term complications following
childhood and adolescent cancer: Foundations for providing risk-
based health care for survivors. CA Cancer J Clin 2004;54:208–
236.
28. Friedman DL, Freyer DR, Levitt GA. Models of care for survivors
of childhood cancer. Pediatr Blood Cancer 2006;46:159–168.
29. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health
conditions in adult survivors of childhood cancer. N Eng J Med
2006;355:1572–1582.
Pediatr Blood Cancer DOI 10.1002/pbc
HRQoL Preschool Cancer Patients After Treatment 1051
